📰 Clinical Development Analytics News
Clinical Development Analytics News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Clinical Development Analytics. Real-time updates on events, politics, business and more.
May 11, 2023
Novartis Gene Therapies' Dr Sitra Tauscher-Wisniewski shares what shaped the success of one of the few commercially-available gene therapies.
March 20, 2023
Children in LT-001 treated after SMA symptom onset maintained or achieved additional milestones up to 7.5 years post one-time intravenous infusionAll...
March 20, 2023
20.03.2023 - Children in LT-001 treated after SMA symptom onset maintained or achieved additional milestones up to 7.5 years post one-time intravenous infusionAll children (100%) in the presymptomatic intravenous cohort of LT-002 maintained or achieved all ...
March 20, 2023
Children in LT-001 treated after SMA symptom onset maintained or achieved additional milestones up to 7.5 years post one-time intravenous infusionAll children (100%) in the presymptomatic intravenous cohort
March 20, 2023
BASEL (dpa-AFX) - Novartis AG (NVS) Monday presented new long-term data of Zolgensma (onasemnogene abeparvovec), the only approved one-time gene therapy for the treatment of spinal muscular atrophy
March 20, 2023
Long-term follow-up study data for Novartis’ one-time gene therapy for spinal muscular atrophy has shown promising milestone achievements.